Home / Products & Performance / GI/Gender Health HHU

HealthShares GI/Gender Health ETF [ HHU ]

HealthShares™ GI/Gender Health ETF (HHU) is one in a series of HealthShares™ ETFs that are organized Vertically by therapeutic categories in pharmaceuticals, healthcare services, life sciences and biotechnology. HHU seeks investment results that correspond to the performance, before the Fund’s fees and expenses, of HealthShares™ GI/Gender Health Index, an equity index of publicly traded common stocks and ADRs. The GI/Gender Health Index invests in healthcare, life sciences and/or biotechnology companies that have been identified as gastrointestinal/genitourinary/gender health companies. Companies included in the GI/Gender Health Index are engaged in the research, clinical development and/or commercialization of therapeutic agents for the treatment of a wide variety of diseases including, but not limited to, gastrointestinal disorders such as gastroesophageal reflux disease, heartburn, irritable bowel syndrome, Crohn’s Disease and ulcerative colitis; genitourinary disorders such as overactive bladder, urge incontinence, stress incontinence and urinary tract infection; and gender health matters including sexual dysfunction (male and female), endometriosis, benign prostatic hyperplasia, prolapsed womb and reproductive health. The companies in this universe are selected using a proprietary methodology developed by XShares Group LLC designed to identify companies in a specific healthcare vertical or sub-sector.

HHU employs a low-cost passive management investment approach designed to track the performance of the HealthShares™ GI/Gender Health Index. Normal brokerage fees apply. HHU will generally invest at least 90% of its assets in common stocks of companies in the underlying Index.

HHU intends to pay out any dividends from its net investment income annually, and plans to distribute any net capital gains annually.

XShares Advisors LLC is the investment advisor for HHU. Bank of New York acts as custodian and administrator.

Market data
Market Price (06/22/2007)* $25.40
Change $-0.39
Volume 200
NAV History     Premium/Discount Chart
Details
NAV as of 07/02/2007 $25.8752
NAV Change $0.3892
Shares Outstanding 100,200
Total Cash $1,307.35
Estimated Cash $1,307.42
Bid as of 07/02/2007 $25.99
Mid point as of 07/02/2007 $26.04
Ask as of 07/02/2007 $26.08
Market Price as of 07/02/2007* N/A
Change N/A
Premium/Discount*** 0.6176%
Yield N/A
Expense ratio as of 07/02/2007 0.75%
Inception date 03/12/2007
Ticker symbol HHU
IOPV** ticker symbol HHU.IV

* Last Sale.

** Indicative Optimized Portfolio Value.

*** Bid/Ask Midpoint versus NAV.